Skip to main content

Helius Medical Technologies, Inc. (HSDT)

NASDAQ: HSDT · IEX Real-Time Price · USD
14.20
-0.23 (-1.59%)
After-hours:Oct 15, 2021 4:26 PM EDT
14.43
0.31 (2.20%)
At close: Oct 15, 4:00 PM
Market Cap34.61M
Revenue (ttm)477,000
Net Income (ttm)-15.36M
Shares Out2.32M
EPS (ttm)-8.68
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,408
Open14.30
Previous Close14.12
Day's Range13.67 - 14.48
52-Week Range11.00 - 600.25
Beta0.84
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About HSDT

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic e...

IndustryHealth Care Equipment & Supplies
CEOPhilippe Deschamps
Employees19
Stock ExchangeNASDAQ
Ticker SymbolHSDT
Full Company Profile

Financial Performance

In 2020, HSDT's revenue was $661,000, a decrease of -55.82% compared to the previous year's $1.50 million. Losses were -$14.13 million, 44.5% more than in 2019.

Financial Statements

News

Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference

NEWTOWN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) --  Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that ...

3 days ago - GlobeNewsWire

Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the ap...

1 month ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

1 month ago - GlobeNewsWire

Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

1 month ago - GlobeNewsWire

New Strong Sell Stocks for August 20th

ADXN, CSSE, HSDT, LYRA, and TRVN have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2021.

Other symbols:ADXNCSSELYRATRVN
1 month ago - Zacks Investment Research

Helius Medical's Neuromodulation Stimulator Nabs FDA Breakthrough Tag

The FDA has granted Breakthrough Device Designation to Helius Medical Technologies Inc's (NASDAQ:HSDT) PoNS device. Related content: Benzinga's Full FDA Calendar.

1 month ago - Benzinga

Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and...

NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

1 month ago - GlobeNewsWire

Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Lags Revenue Estimates

Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of -68.63% and -21.11%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for ...

2 months ago - Zacks Investment Research

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today ann...

2 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

2 months ago - GlobeNewsWire

Will Helius Medical Technologies, Inc. (HSDT) Report Negative Earnings Next Week? What You Should Know

Helius Medical Technologies, Inc. (HSDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

3 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

3 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Th...

Company Selected to Receive the “Pioneer in Technology Award” Company Selected to Receive the “Pioneer in Technology Award”

3 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

NEWTOWN, Pa., June 30, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

3 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Participate in Noble Capital Markets' Virtual Road Show Series

NEWTOWN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

4 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

4 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results

NEWTOWN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported...

4 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st

NEWTOWN, Pa., April 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

6 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

NEWTOWN, Pa., April 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

6 months ago - GlobeNewsWire

Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device

First and only tongue-delivered neuromodulation therapy provides new treatment option for U.S. patients living with gait deficit due to symptoms from multiple sclerosis First and only tongue-delivered n...

6 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd

NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

6 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...

6 months ago - GlobeNewsWire

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

NEWTOWN, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today report...

7 months ago - GlobeNewsWire

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021

NEWTOWN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...

8 months ago - GlobeNewsWire